These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

300 related items for PubMed ID: 22105527

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Bortezomib and extramedullary disease in multiple myeloma: the shine and dark side of the moon.
    Ali R, Ozkalemkas F, Ozkan A, Ozkocaman V, Ozcelik T, Ozan U, Kurt M, Tunali A.
    Leuk Res; 2007 Aug; 31(8):1153-5. PubMed ID: 16945413
    [No Abstract] [Full Text] [Related]

  • 4. Hepatic plasmacytosis as a manifestation of relapse in multiple myeloma treated with thalidomide.
    del Giglio A, Weinschenker P, Manhani AR, Carbonell AL, Mitteldorf CA.
    South Med J; 2005 Feb; 98(2):238-40. PubMed ID: 15759959
    [Abstract] [Full Text] [Related]

  • 5. [A clinical analysis of 25 cases of multiple myeloma complicated by extramedullary plasmacytomas].
    Zhong YP, Chen SL.
    Zhonghua Nei Ke Za Zhi; 2009 May; 48(5):396-8. PubMed ID: 19615158
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Soft-tissue plasmacytomas in multiple myeloma: incidence, mechanisms of extramedullary spread, and treatment approach.
    Bladé J, Fernández de Larrea C, Rosiñol L, Cibeira MT, Jiménez R, Powles R.
    J Clin Oncol; 2011 Oct 01; 29(28):3805-12. PubMed ID: 21900099
    [Abstract] [Full Text] [Related]

  • 8. [Four cases of an extramedullary plasmacytoma of the head and neck].
    Tateno K, Kawashima M, Matuura M, Maehara Y, Sakaino K, Simizu R, Satake B, Makino S, Matuura S, Shimano S.
    Gan No Rinsho; 1990 Jan 01; 36(1):81-6. PubMed ID: 1688960
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Lenalidomide is active for extramedullary disease in refractory multiple myeloma.
    Nakazato T, Mihara A, Ito C, Sanada Y, Aisa Y.
    Ann Hematol; 2012 Mar 01; 91(3):473-4. PubMed ID: 21647581
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Three cases of bortezomib-resistant multiple myeloma with extramedullary masses.
    Moriuchi M, Ohmachi K, Kojima M, Tsuboi K, Ogawa Y, Nakamura N, Ando K.
    Tokai J Exp Clin Med; 2010 Apr 20; 35(1):17-20. PubMed ID: 21319020
    [Abstract] [Full Text] [Related]

  • 17. Neoadjuvant therapy in a patient with clival plasmacytoma associated with multiple myeloma: a case report.
    Yamaguchi S, Terasaka S, Ando S, Shinohara T, Iwasaki Y.
    Surg Neurol; 2008 Oct 20; 70(4):403-7. PubMed ID: 18291467
    [Abstract] [Full Text] [Related]

  • 18. Plasmacytoma relapses in the absence of systemic progression post-high-dose therapy for multiple myeloma.
    Terpos E, Rezvani K, Basu S, Milne AE, Rose PE, Scott GL, Rahemtulla A, Samson D, Apperley JF.
    Eur J Haematol; 2005 Nov 20; 75(5):376-83. PubMed ID: 16191086
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Multiple extramedullary plasmacytomas from the whole respiratory system].
    Kanoh T, Amitani R.
    Rinsho Ketsueki; 1997 Mar 20; 38(3):217-21. PubMed ID: 9095661
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.